FDA vaccine advisers reject Pfizer's application to add a booster to its two-dose coronavirus vaccine regimen
Biden officials say Covid-19 vaccine booster plan was rolled out for transparency and planningby the White House in which it said it was preparing to roll out booster Covid-19 shots for most Americans by Sept. 20 – well ahead of any consideration by the US Food and Drug Administration and the US Centers for Disease Control and Prevention – saying they were just trying to plan ahead.
Scientific leaders in the administration, Murthy said, “had said publicly that we were following the data closely, and if we saw a signal that indicated to us that protection was starting to wane, and that additional shots may be required, that we would be transparent and open with the public about that. That was one of the reasons we felt it was important to speak up when we saw that signal in the data.
Murthy noted that administration officials have always been clear that the plan “would be contingent on the FDA and the CDC’s independent evaluation” and that they will follow that evaluation and the recommendations.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Read more »
FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Read more »
FDA panel is first key test for Biden COVID-19 booster planGovernment advisers are debating whether to recommend extra doses of the Pfizer vaccine, a key step toward the Biden administration's plan to dispense COVID-19 booster shots. Scientists have been divided over the need for boosters and who should get them.
Read more »
FDA Panel Weighs Covid-19 Booster Shots as Health Officials Debate NeedThe Biden administration’s push to introduce widespread vaccine boosters faces a test as a Food and Drug Administration advisory panel meets to weigh evidence on the extra shots, a topic that has divided federal health officials.
Read more »
FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine boosterA panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc /BioNTech SE COVID-19 vaccine for people aged 16 and older.
Read more »
What to expect as FDA advisory panel debates Pfizer COVID booster shotsThe FDA's independent advisory committee is convening to review data submitted by Pfizer and discuss whether a booster dose is safe enough for widespread use and whether it's necessary and effective at improving protection levels against COVID-19.
Read more »